Nuwellis (NUWE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Jul, 2026Executive summary
Special meeting scheduled for July 24, 2026, to vote on three key proposals, including warrant exercise, reverse stock split, and potential adjournment to solicit more proxies.
Board unanimously recommends voting in favor of all proposals to support capital structure and Nasdaq compliance.
Meeting will be held virtually, allowing shareholders to participate and vote online.
Voting matters and shareholder proposals
Proposal 1 seeks approval for issuance of up to 2,396,709 shares upon exercise of warrants from a June 2026 financing and repriced outstanding warrants, in compliance with Nasdaq Rule 5635(d).
Proposal 2 requests approval for a reverse stock split at a ratio between 1-for-5 and 1-for-70, at the Board's discretion, to maintain Nasdaq listing requirements.
Proposal 3 authorizes adjournment of the meeting to solicit additional proxies if needed for Proposals 1 or 2.
Each proposal requires a majority of votes cast for approval; abstentions and broker non-votes generally do not affect outcomes.
Board of directors and corporate governance
Board retains discretion to determine the reverse split ratio and timing within twelve months of approval.
No directors or executive officers have substantial interests in the warrant proposal beyond their shareholdings.
Board may abandon the reverse split if deemed not in the best interests of shareholders.
Latest events from Nuwellis
- Q2 2026 revenue up 14%, gross margin at 76%, net loss narrowed, but Nasdaq risks persist.NUWE
Q2 2026 - Votes are sought for warrant share issuance, a reverse split, and meeting adjournment to maintain compliance.NUWE
Proxy filing - Best-efforts offering targets $4.4M for working capital, with high dilution and ongoing losses.NUWE
Registration filing - Pediatric and critical care growth, innovation, and operational discipline drive revenue momentum.NUWE
Investor presentation - Offering up to $4.4M in equity and warrants, with high dilution and operational risks.NUWE
Registration filing - Up to $4.4M sought via equity and warrants to fund operations amid high product and financial risk.NUWE
Registration filing - Revenue up 26% to $2.4M, gross margin 70.1%, net loss $4.5M, with new patents and capital needs.NUWE
Q1 2026 - Updated share count, board changes, and voting details for the April 2026 Annual Meeting.NUWE
Proxy filing - Board seeks approval for director elections and auditor ratification, emphasizing governance.NUWE
Proxy filing